| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 房地产开发销售(元) | 2,065,547,958.80 | 1,387,363,481.72 | 557,283,071.62 | 445,641,044.09 |
| 市政基础设施承建(元) | 446,473,893.20 | 106,089,850.61 | 808,047,498.14 | 429,772,309.08 |
| 园区管理及服务(元) | 298,193,028.63 | 149,138,171.69 | 345,687,184.46 | 168,357,989.03 |
| 药品销售(元) | 538,213,642.36 | 250,153,239.72 | 264,427,648.89 | - |
| 土地成片开发转让(元) | 64,275,349.50 | 64,275,349.50 | - | - |
| 营业成本(元) | ||||
| 房地产开发销售(元) | 1,727,743,066.66 | 1,188,824,614.21 | 431,416,584.57 | 382,009,582.93 |
| 市政基础设施承建(元) | 406,708,793.64 | 94,141,887.47 | 739,386,040.83 | 382,886,819.81 |
| 园区管理及服务(元) | 185,755,660.57 | 80,748,806.50 | 225,750,534.26 | 102,310,325.57 |
| 药品销售(元) | 280,700,505.32 | 125,435,255.69 | 146,642,327.44 | - |
| 土地成片开发转让(元) | 25,192,169.25 | 26,976,454.50 | - | - |
| 毛利(元) | ||||
| 房地产开发销售(元) | 337,804,892.14 | 198,538,867.51 | 125,866,487.05 | 63,631,461.16 |
| 市政基础设施承建(元) | 39,765,099.56 | 11,947,963.14 | 68,661,457.31 | 46,885,489.27 |
| 园区管理及服务(元) | 112,437,368.06 | 68,389,365.19 | 119,936,650.20 | 66,047,663.46 |
| 药品销售(元) | 257,513,137.04 | 124,717,984.03 | 117,785,321.45 | - |
| 土地成片开发转让(元) | 39,083,180.25 | 37,298,895.00 | - | - |
| 毛利率(%) | ||||
| 房地产开发销售(%) | 16.35 | 14.31 | 22.59 | 14.28 |
| 市政基础设施承建(%) | 8.91 | 11.26 | 8.50 | 10.91 |
| 园区管理及服务(%) | 37.71 | 45.86 | 34.70 | 39.23 |
| 药品销售(%) | 47.85 | 49.86 | 44.54 | - |
| 土地成片开发转让(%) | 60.81 | 58.03 | - | - |
| 收入构成(%) | ||||
| 房地产开发销售(%) | 60.53 | 70.89 | 28.21 | 42.70 |
| 市政基础设施承建(%) | 13.08 | 5.42 | 40.90 | 41.17 |
| 园区管理及服务(%) | 8.74 | 7.62 | 17.50 | 16.13 |
| 药品销售(%) | 15.77 | 12.78 | 13.39 | - |
| 土地成片开发转让(%) | 1.88 | 3.28 | - | - |
| 毛利构成(%) | ||||
| 房地产开发销售(%) | 42.94 | 45.03 | 29.12 | 36.04 |
| 市政基础设施承建(%) | 5.06 | 2.71 | 15.88 | 26.55 |
| 园区管理及服务(%) | 14.29 | 15.51 | 27.75 | 37.41 |
| 药品销售(%) | 32.74 | 28.29 | 27.25 | - |
| 土地成片开发转让(%) | 4.97 | 8.46 | - | - |